Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,676 | 44 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| MannKind Corporation | $358.40 | 7 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $328.82 | 3 | $0 (2024) |
| Amarin Pharma Inc. | $154.85 | 4 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $139.77 | 2 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $132.98 | 2 | $0 (2020) |
| Merck Sharp & Dohme LLC | $124.35 | 10 | $0 (2022) |
| Kowa Pharmaceuticals America, Inc. | $123.55 | 2 | $0 (2019) |
| Horizon Therapeutics plc | $115.16 | 1 | $0 (2019) |
| SK Life Science, Inc. | $41.00 | 3 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $36.60 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $345.36 | 4 | AstraZeneca Pharmaceuticals LP ($328.82) |
| 2023 | $74.62 | 1 | MannKind Corporation ($74.62) |
| 2022 | $86.58 | 6 | SK Life Science, Inc. ($26.08) |
| 2021 | $194.73 | 6 | MannKind Corporation ($124.99) |
| 2020 | $300.81 | 7 | Amarin Pharma Inc. ($141.61) |
| 2019 | $462.71 | 12 | Mannkind Corporation ($158.79) |
| 2018 | $86.29 | 6 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($36.60) |
| 2017 | $125.37 | 2 | Kowa Pharmaceuticals America, Inc. ($110.31) |
All Payment Transactions
44 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/14/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $92.73 | General |
| Category: Respiratory | ||||||
| 05/06/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Obesity | ||||||
| 03/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Respiratory | ||||||
| 02/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $111.10 | General |
| Category: Respiratory | ||||||
| 10/26/2023 | MannKind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $74.62 | General |
| Category: DIABETES MEDICINE | ||||||
| 06/07/2022 | Banner Life Sciences, LLC | BAFIERTAM (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Immune | ||||||
| 05/10/2022 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $12.16 | General |
| 04/19/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $11.85 | General |
| Category: ONCOLOGY | ||||||
| 03/01/2022 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $13.92 | General |
| 02/14/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: RESPIRATORY | ||||||
| 02/07/2022 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 07/27/2021 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug), JANUVIA, STEGLATRO | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/22/2021 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug), JANUVIA, JANUMET | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/06/2021 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $14.58 | General |
| Category: Neurology | ||||||
| 06/03/2021 | MannKind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: DIABETES MEDICINE | ||||||
| 05/20/2021 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $14.92 | General |
| 03/25/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Cardiovascular | ||||||
| 12/03/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Cardiovascular | ||||||
| 11/19/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $9.81 | General |
| Category: Cardiovascular | ||||||
| 08/06/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/06/2020 | Arbor Pharmaceuticals, Inc. | Edarbyclor (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/25/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $118.09 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/12/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $117.08 | General |
| Category: Cardiovascular | ||||||
| 02/07/2020 | Arbor Pharmaceuticals, Inc. | Edarbyclor (Drug) | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/07/2019 | Horizon Therapeutics plc | RAYOS (Drug), RAYOS, RAYOS | Food and Beverage | Cash or cash equivalent | $115.16 | General |
| Category: RAYOS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 84 | 87 | $44,000 | $8,797 |
| 2022 | 6 | 123 | 125 | $64,480 | $15,520 |
| 2021 | 5 | 106 | 113 | $55,930 | $11,974 |
| 2020 | 7 | 197 | 213 | $105,910 | $25,122 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 76700 | Complete ultrasound scan of abdomen | Office | 2023 | 34 | 36 | $18,000 | $3,872 | 21.5% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 19 | 20 | $10,000 | $2,004 | 20.0% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2023 | 19 | 19 | $9,500 | $1,709 | 18.0% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 12 | 12 | $6,500 | $1,211 | 18.6% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2022 | 12 | 13 | $7,800 | $3,046 | 39.0% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2022 | 28 | 29 | $14,210 | $2,902 | 20.4% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2022 | 33 | 33 | $16,500 | $2,870 | 17.4% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2022 | 15 | 15 | $7,500 | $2,650 | 35.3% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2022 | 23 | 23 | $11,270 | $2,231 | 19.8% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 12 | 12 | $7,200 | $1,822 | 25.3% |
| 76770 | Ultrasound behind abdominal cavity | Office | 2021 | 28 | 30 | $14,700 | $3,004 | 20.4% |
| 93978 | Ultrasound scan of vena cava or groin graft or vessel blood flow | Office | 2021 | 16 | 16 | $8,000 | $2,895 | 36.2% |
| 76700 | Ultrasound of abdomen, complete | Office | 2021 | 24 | 26 | $13,000 | $2,665 | 20.5% |
| 76856 | Ultrasound of pelvis, complete, not pregnancy related | Office | 2021 | 24 | 27 | $13,230 | $2,638 | 19.9% |
| 76604 | Ultrasound of chest | Office | 2021 | 14 | 14 | $7,000 | $771.43 | 11.0% |
| 93978 | Ultrasound scan of vena cava or groin graft or vessel blood flow | Office | 2020 | 37 | 41 | $20,500 | $7,268 | 35.5% |
| 76700 | Ultrasound of abdomen | Office | 2020 | 38 | 43 | $21,500 | $4,646 | 21.6% |
| 76770 | Ultrasound behind abdominal cavity | Office | 2020 | 32 | 34 | $16,660 | $3,293 | 19.8% |
| 93970 | Ultrasound scan of veins of both arms or legs including assessment of compression and functional maneuvers | Office | 2020 | 16 | 16 | $8,000 | $2,955 | 36.9% |
| 76604 | Ultrasound of chest | Office | 2020 | 36 | 40 | $20,000 | $2,890 | 14.4% |
| 76856 | Ultrasound of pelvis | Office | 2020 | 25 | 25 | $12,250 | $2,546 | 20.8% |
| 76536 | Ultrasound of head and neck | Office | 2020 | 13 | 14 | $7,000 | $1,525 | 21.8% |
About Dr. Marc Simonson, MD
Dr. Marc Simonson, MD is a Diagnostic Radiology healthcare provider based in Union City, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902973589.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marc Simonson, MD has received a total of $1,676 in payments from pharmaceutical and medical device companies, with $345.36 received in 2024. These payments were reported across 44 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,676).
As a Medicare-enrolled provider, Simonson has provided services to 510 Medicare beneficiaries, totaling 538 services with total Medicare billing of $61,413. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Diagnostic Radiology
- Location Union City, NJ
- Active Since 11/29/2006
- Last Updated 07/08/2007
- Taxonomy Code 2085R0202X
- Entity Type Individual
- NPI Number 1902973589
Products in Payments
- AFREZZA (Drug) $358.40
- AIRSUPRA (Drug) $236.09
- Vascepa (Drug) $154.85
- XARELTO (Drug) $132.98
- Livalo (Drug) $123.55
- RAYOS (Drug) $115.16
- BREZTRI (Drug) $92.73
- JANUVIA (Drug) $85.50
- XIFAXAN (Drug) $36.60
- BELSOMRA (Drug) $27.00
- Edarbyclor (Drug) $26.22
- Yupelri (Drug) $18.36
- ZEPBOUND (Drug) $16.54
- BAFIERTAM (Drug) $15.50
- Veltassa (Drug) $14.90
- TOUJEO (Drug) $14.89
- OFEV (Drug) $14.79
- Dayvigo (Drug) $14.58
- KEYTRUDA (Biological) $11.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.